MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lysosomal disorders"

  • 2024 International Congress

    Bi-allelic BORCS5 Variants Result In A Wide Spectrum of Progressive Neurodevelopmental Disorders via Lysosomal Dysfunction

    NE. Mencacci, G. Minakaki, R. Maroofian, R. de Pace, F. Magrinelli, S. Eldessouky, WJ. Peng, B. Doan, J. Baptista, T. Marton, J. Vogt, JD. Ortigoza-Escobar, L. Martorell, EJ. Kamsteeg, A. Mahmoud, A. Scardamaglia, MS. Zaki, G. Zifarelli, Z. Alhassnan, NW. Wood, M. Schwake, J. Bonifacino, H. Houlden, KP. Bhatia, D. Krainc (Chicago, USA)

    Objective: To characterize a new brain disorder associated with BORCS5 variants, elucidating their effect on lysosomal distribution and activity Background: BORCS5 encodes a subunit of…
  • 2024 International Congress

    Prevalence of Parkinson’s Disease and Possible Parkinsonian Syndrome in Gaucher Disease: Data From the ICGG Gaucher Registry

    R. Alcalay, P. Mistry, A. Di Fonzo, J. Batista, P. Bianculli, J. Carwile, G. Perichon, M. Balwani (New York, USA)

    Objective: To estimate the age-specific risk of Parkinson’s disease (PD) and possible parkinsonian syndrome (pPS) in Gaucher disease (GD) based on registry data. Background: While…
  • 2024 International Congress

    Lysosomal network defects in parkinsonian patients carrying rare variants in lysosomal hydrolytic enzyme genes

    J. Hoenicka, A. Pascual, O. de Fàbregues, M. Frias, L. Vela, M. de Lucca, P. García-Ruiz, C. Feliz, M. Marchen, R. Repossi, G. Fernández, M. Roldán, F. Palau (Esplugues de Llobregat, Spain)

    Objective: Functional validation of rare variants of lysosomal genes potentially associated with early onset Parkinson's disease (EOPD) Background: The genetic load in EOPD is high;…
  • 2024 International Congress

    V-ATPase subunit V1G1 overexpression conferred the mice neuroprotection during MPTP exposure

    YIM. Wang, Y. Li, Y. Xia, L. Kou, T. Wang (武汉市, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton ATPase subunit G (V1G1) in the degradation and…
  • 2024 International Congress

    Interaction of GCase and ganglioside GM1 in the aggregation of α-Synuclein

    F. Fierli, G. Uras, S. Lucas-Del Pozo, S. Koletsi, V. Lentini, M. Toffoli, P. Caboni, A. Schapira (London, United Kingdom)

    Objective: The objective of this work is to investigate the relationship between ganglioside GM1 levels and α-synuclein aggregation in the context of GBA1 mutations. Background:…
  • 2023 International Congress

    A juvenile onset Sandhoff disease case caused by hemizygous mutations of HEXB

    JH. Yin (Beijing, China)

    Objective: Sandhoff disease (SD) is a rare neurological disease with high clinical heterogeneity. SD in juvenile form is much rarer and it is often misdiagnosed…
  • 2023 International Congress

    Impaired lysophagy function exacerbates propagation of α-synuclein aggregation

    K. Kakuda, K. Ikenaka, C. Aguirre, C. Choong, J. Doi, Y. Kimura, H. Mochizuki (Osaka, Japan)

    Objective: We aimed to clarify how exogenous αSyn aggregates interact with native αSyn in the cytoplasm and seed aggregation, and what defense mechanisms protect against…
  • 2023 International Congress

    Glucocerebrosidase (GCase) activator, Ambroxol, reduces alpha-synuclein serine-129 phosphorylation and oligomers in mutant LRRK2 R1441G mouse brains

    Z. Choi, E. Chang, H. Liu, S. Zhang, Y. Ruan, K. Leung, S. Pang, M. Kung, D. Ramsden, S. Ho, P. Ho (Hong Kong, Hong Kong)

    Objective: To explore whether inducing brain GCase activity by Ambroxol™ (ABX; a brain-penetrant GCase activator) can reduce a-synuclein (αSyn) serine-129 phosphorylation and oligomer accumulation in…
  • 2023 International Congress

    The spectrum of GBA mutations in the Korean population with Parkinson’s disease

    J. Hwangbo, J. Lee, SC. Cheon, KS. Park (Yangsan, Republic of Korea)

    Objective: We investigated the mutation spectrum of glucocerebrosidase (GBA) gene in Korean patients with Parkinson’s disease (GBA-PD). Background: Mutations in the GBA gene represent important…
  • 2023 International Congress

    Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

    S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)

    Objective: To explore the regional cholinergic innervation and clinical profile of early Parkinson’s disease (PD) patients carrying GBA mutations (GBA-PD). Background: The most common genetic…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley